Dr. Fang Jianmin, Executive Director, co-founder, and CEO of RemeGen.

Dr. Fang Jianmin received his PhD in Biology from Dalhousie University in Canada in 1998. From 1997 to 2000. He conducted postdoctoral research focusing on cancer in the Department of Surgery, Harvard Medical School and Boston Children’s Hospital. He holds more than 50 drug-related invention patents and is the inventor of the novel biopharmaceuticals, Telitacicept and Disitamab Vedotin. He served as a member of the overall expert group for the national science and technology significant project “Significant New Drug Creation” during the “Twelfth Five-Year Plan” and “Thirteenth Five-Year Plan”, and won the National Distinguished Expert from the Organization Department of the Central Committee of the Communist Party of China, the “Taishan Scholar” of Shandong Province, and the “Qilu Outstanding Talent Award” and other titles and honors. Currently, he is a professor and doctoral supervisor at the School of Life Sciences and Technology, Tong Ji University.